BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 34108686)

  • 1. TIM-3 restrains anti-tumour immunity by regulating inflammasome activation.
    Dixon KO; Tabaka M; Schramm MA; Xiao S; Tang R; Dionne D; Anderson AC; Rozenblatt-Rosen O; Regev A; Kuchroo VK
    Nature; 2021 Jul; 595(7865):101-106. PubMed ID: 34108686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of Nod-like receptor protein 3 inflammasome activation by T cell Ig mucin-3 protects against peritonitis.
    Wang W; Shi Q; Dou S; Li G; Shi X; Jiang X; Wang Z; Yu D; Chen G; Wang R; Xiao H; Hou C; Feng J; Shen B; Ma Y; Han G
    Immunology; 2018 Jan; 153(1):71-83. PubMed ID: 28799242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tim-3 exacerbates kidney ischaemia/reperfusion injury through the TLR-4/NF-κB signalling pathway and an NLR-C4 inflammasome activation.
    Guo Y; Zhang J; Lai X; Chen M; Guo Y
    Clin Exp Immunol; 2018 Jul; 193(1):113-129. PubMed ID: 29570768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy.
    Prokopi A; Tripp CH; Tummers B; Hornsteiner F; Spoeck S; Crawford JC; Clements DR; Efremova M; Hutter K; Bellmann L; Cappellano G; Cadilha BL; Kobold S; Boon L; Ortner D; Trajanoski Z; Chen S; de Gruijl TD; Idoyaga J; Green DR; Stoitzner P
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33408092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Src Suppresses Dendritic Cell Antitumor Activity via T Cell Ig and Mucin Protein-3 Receptor.
    Gujar R; Maurya N; Yadav V; Gupta M; Arora S; Khatri N; Sen P
    J Immunol; 2016 Sep; 197(5):1650-62. PubMed ID: 27439518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania donovani Impedes Antileishmanial Immunity by Suppressing Dendritic Cells via the TIM-3 Receptor.
    Akhtar MN; Kumar S; Sen P
    mBio; 2022 Aug; 13(4):e0330921. PubMed ID: 35924848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment.
    Banerjee H; Nieves-Rosado H; Kulkarni A; Murter B; McGrath KV; Chandran UR; Chang A; Szymczak-Workman AL; Vujanovic L; Delgoffe GM; Ferris RL; Kane LP
    Cell Rep; 2021 Sep; 36(11):109699. PubMed ID: 34525351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tim-3 signaling blockade with α-lactose induces compensatory TIGIT expression in Plasmodium berghei ANKA-infected mice.
    Zhang Y; Jiang N; Zhang T; Chen R; Feng Y; Sang X; Yang N; Chen Q
    Parasit Vectors; 2019 Nov; 12(1):534. PubMed ID: 31711531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8
    Gardner A; de Mingo Pulido Á; Hänggi K; Bazargan S; Onimus A; Kasprzak A; Conejo-Garcia JR; Rejniak KA; Ruffell B
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34987021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms.
    Andersen K; Eltrich N; Lichtnekert J; Anders HJ; Vielhauer V
    Kidney Int; 2014 Nov; 86(5):965-78. PubMed ID: 24805106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin L3 From
    Celias DP; Corvo I; Silvane L; Tort JF; Chiapello LS; Fresno M; Arranz A; Motrán CC; Cervi L
    Front Immunol; 2019; 10():552. PubMed ID: 30967874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease.
    Oikawa T; Kamimura Y; Akiba H; Yagita H; Okumura K; Takahashi H; Zeniya M; Tajiri H; Azuma M
    J Immunol; 2006 Oct; 177(7):4281-7. PubMed ID: 16982862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.
    Simovic Markovic B; Nikolic A; Gazdic M; Bojic S; Vucicevic L; Kosic M; Mitrovic S; Milosavljevic M; Besra G; Trajkovic V; Arsenijevic N; Lukic ML; Volarevic V
    J Crohns Colitis; 2016 May; 10(5):593-606. PubMed ID: 26786981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
    Huang YH; Zhu C; Kondo Y; Anderson AC; Gandhi A; Russell A; Dougan SK; Petersen BS; Melum E; Pertel T; Clayton KL; Raab M; Chen Q; Beauchemin N; Yazaki PJ; Pyzik M; Ostrowski MA; Glickman JN; Rudd CE; Ploegh HL; Franke A; Petsko GA; Kuchroo VK; Blumberg RS
    Nature; 2015 Jan; 517(7534):386-90. PubMed ID: 25363763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Tim-3 in regulating tumorigenesis, inflammation, and antitumor immunity therapy.
    Cao Y; Li Q; Liu H; He X; Huang F; Wang Y
    Cancer Biomark; 2021; 32(2):237-248. PubMed ID: 34092621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined TIM-3 and PD-1 blockade restrains hepatocellular carcinoma development by facilitating CD4+ and CD8+ T cell-mediated antitumor immune responses.
    Zhang XS; Zhou HC; Wei P; Chen L; Ma WH; Ding L; Liang SC; Chen BD
    World J Gastrointest Oncol; 2023 Dec; 15(12):2138-2149. PubMed ID: 38173440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific CD8
    Yao Y; Chen S; Cao M; Fan X; Yang T; Huang Y; Song X; Li Y; Ye L; Shen N; Shi Y; Li X; Wang F; Qian Y
    Nat Commun; 2017 May; 8():15402. PubMed ID: 28537251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4
    Luo J; Pang S; Hui Z; Zhao H; Xu S; Yu W; Yang L; Sun Q; Hao X; Wei F; Wang J; Ren X
    Theranostics; 2023; 13(14):4836-4857. PubMed ID: 37771774
    [No Abstract]   [Full Text] [Related]  

  • 20. β-Catenin in Dendritic Cells Negatively Regulates CD8 T Cell Immune Responses through the Immune Checkpoint Molecule Tim-3.
    Fu C; Wang J; Ma T; Yin C; Zhou L; Clausen BE; Mi QS; Jiang A
    Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.